Tetracycline therapy for muscle atrophy due to immobilization

Journal of Musculoskeletal Neuronal Interactions

Volumn 9, Issue 2, 2009, Pages 81-88

  Carmeli, Eli ^a   Kodesh, E ^b   Nemcovsky, C ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF HAIFA   (Israel)

Author keywords

Atrophy; Immobilization; Skeletal muscle; Tetracycline

Indexed keywords

GELATINASE A; HEAT SHOCK PROTEIN 70; MESSENGER RNA; TETRACYCLINE; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG RESPONSE; FAST MUSCLE FIBER; FRACTURE EXTERNAL FIXATION; GASTROCNEMIUS MUSCLE; GENE EXPRESSION REGULATION; IMMOBILIZATION; KNEE; MUSCLE ATROPHY; MUSCLE LEVEL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLOW MUSCLE FIBER; SOLEUS MUSCLE; UPREGULATION; WESTERN BLOTTING; WISTAR RAT; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION; METABOLISM; SKELETAL MUSCLE;

ANIMALS; BLOTTING, WESTERN; GENE EXPRESSION; HSP70 HEAT-SHOCK PROTEINS; IMMOBILIZATION; MATRIX METALLOPROTEINASE 2; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRACYCLINE;

EID: 68849112687     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Hasselgren PO Fischer JE. The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions. Ann Surg 1997;225:307-316
2. Jagoe RT, Goldberg AL. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care 2001;4:183-190
3. Powers SK, Kavazis AN, DeRuisseau KC. Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 2005;288:R337-44
4. Shefer G, Carmeli E, Rauner G, Yablonka-Reuveni Z, Benayahu D.. Exercise running and tetracycline as means to enhance skeletal muscle stem cell performance after external fixation. J Cell Physiol 2008;215: 265-275
5. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJ. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526-534 (Pubitemid 27329429)
6. Tsutsui H, Ide T, Hayashidani S, Suematsu N, Shiomi T, Wen J, Nakamura Ki, Ichikawa K, Utsumi H, Takeshita A. Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation 2001;104:134-136 (Pubitemid 32655826)
7. Kondo H, Nakagaki I, Sasaki S, Hori S, Itokawa Y. Mechanism of oxidative stress in skeletal muscle atrophied by immobilization. Am J Physiol Endocrinol Metab 1993;265:E839-E44.
8. Costelli P, Tullio RD, Baccino FM, Melloni E. Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br J Cancer 2001;84:946-950
9. Valdez H, Lederman MM. Cytokines and cytokine therapies in HIV infection. AIDS. Clin Rev 1998; 88:187-228.
10. Reznick AZ, Volpin G, Ben-Ari H, Silbermann M, Stein H. Biochemical and morphological studies on rat skeletal muscles following prolonged immobilization of the knee joint by external fixation and plaster cast: a comparative study. Eur J Musculoskel Res 1995;4:69-76. (Pubitemid 26045188)
11. Booth FW. Effect of limb immobilization on skeletal muscle. J Appl Physiol 1982;52:1113-1118
12. Fitts RH, Metzger JM, Riley DA, Unsworth B. Models of disuse: a comparison of hindlimb suspension and immobilization. J Appl Physiol 1986;60:1946-1953 (Pubitemid 16066958)
13. Carmeli E, Moas M, Reznick AZ, Coleman R. MMPs and skeletal muscle. Muscle & Nerve 2003;29:191-197
14. Carmeli E, Wertheim M. MMP-2, MMP-9 and SOD as biological markers for structuring the individual training process. LeistongsSport 2004;6:40-43.
15. McArdle A, Vasilaki A, Jackson M. Exercise and skeletal muscle aging: cellular and molecular mechanisms. Aging Res Rev 2002;1:79-93. (Pubitemid 38340353)
16. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001;13:534-540
17. Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 1998;12:1075-1095 (Pubitemid 28418938)
18. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
19. Kherif S, Lafuma C, Dehaupas M, Lachkar S, Fournier JG, Verdiere-Sahuque M, Fardeau M, Alameddine HS. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol 1999;205:158-170 (Pubitemid 29042665)
20. Choi YC, Dalakas MC. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurol 2000;54:65-71. (Pubitemid 30038739)
21. Reznick AZ, Menashe O, Bar-Shai M, Coleman R, Carmeli. E. Expression of matrix metalloproteinases, inhibitor, and acid phosphatase in muscles of immobilized hindlimbs of rats. Muscle & Nerve 2003;26:51-59 (Pubitemid 36083444)
22. Carmeli E, Moas M, Lennon L, Powers SK. High intensity exercise increases expression of matrix metalloproteinases in fast skeletal muscle fibers. Exp Physiol 2005;90:613-619 (Pubitemid 40980162)
23. Morgunova E, Tuuttila A, Bergmann U, Tryggvason K. Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc Natl Acad Sci USA 2002;99: 7414-7419 (Pubitemid 34568705)
24. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995;270:5331-5338
25. Kieseier BC, Schneider C, Clements JM, Gearing AJH, Gold R, Toyka KV, Hartung HP. Expression of specific matrix metalloproteinases in inflammatory myopathies. Brain 2001;124:341-351 (Pubitemid 32142406)
26. Powers SK, Lennon SL. Analysis of cellular responses to free radicals: focus on exercise and skeletal muscle. Proc Nutr Soc 1999;58:1025-1033
27. Van Gieson EJ, Skalak TC. Chronic vasodilation induces matrix metalloproteinase 9 (MMP-9) expression during microvascular remodeling in rat skeletal muscle. Microcirculation 2001;8:25-31.
28. Lawler JM, Song W, Demaree SR. Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle. Free Radic Biol Med 2003;35:9-16. (Pubitemid 36782333)
29. Rogalla T, Ehrnsperger M, Preville X, Kotlyarov A, Lutsch G, Ducasse C, et al., Regulation of HSP27 oligimerization, chaperone, function, and protective activity against oxidative stress/tumor necrosis factor by phosphorylation. J Biol Chem 1999;274:18847-18956 (Pubitemid 129519312)
30. Koh TJ. Do small heat shock proteins protect skeletal muscle from injury? Exerc Sports Sci Rev 2002;30:117-121
31. Lalu MM, Csonka C, Giricz Z, Csont T, Schultz R, Ferdinandy P. Preconditioning decreases ischemia/reperfusion- induced release and activation of matrix metalloproteinase -2. Biochem Biophys Res Commun 2002; 296:937-941
32. Naito H, Powers SK, Demirel HA, Suguira T, Dodd SL, Aoki J. Heat stress attenuates skeletal muscle atrophy in hindlimb-unweighted rats. J Appl Physiol 2000; 88:359-363 (Pubitemid 30053868)
33. Schlesinger MJ. Heat shock proteins. J Biol Chem 1990; 265:12111-12114
34. Chopard A, Pons A, Marini J. Cytoskeletal protein contents before and after hindlimb suspension in a fast and slow rat skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2001;280:R323-30. (Pubitemid 32479672)
35. Tsika RW, Herrick RE, Baldwin KM. Interaction of compensatory overload and hindlimb suspension on myosin isoform expression. J Appl Physiol 1987;62:2180-2186 (Pubitemid 17093426)
36. Lieber RL, McKee-Woodburn T, Gershuni DH. Recovery of the dog quadriceps after 10 weeks of immobilization followed by 4 weeks of remobilization. J Orthop Res 1989;7:408-412 (Pubitemid 19132859)
37. Lamparter S, Slight SH, Weber KT. Doxycycline and tissue repair in rats. J Lab Clin Med 2002;139:295-302.
38. Nelson MW. Chemical and biological dynamics of tetracycline. Adv Dent Res 1998;12:5-11.
39. Golub LM, Wolff M, Roberts S, Lee HM, Leung M, Payonk G. Treating periodontal diseases by blocking tissue-destructive enzymes. J Am Dent Ass 1994; 12:5163-5169
40. Greenwald RA. Treatment of destructive arthritic disorders with MMP inhibitors. Ann NY Acad Sci 1994; 732:181-198
41. Greenwald RA, Moak SA, Ramamurthy N, Golub LM. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 1992; 19:927-938
42. Fisher JS, Brown M. Immobilization effects on contractile properties of aging rat skeletal muscle. Aging 1998; 10:59-66. (Pubitemid 28216183)
43. Rivilis I, Milkiewicz M, Boyd P, Goldstein J, Brown MD, Egginton S, Hansen FM, Hudlicka O, Haas TL. Differential involvement of MMP-2 and VEGF during muscle stretch - versus shear stress-induced angiogenesis. Am J Physiol Heart Circ Physiol 2002;283:H1430-438. (Pubitemid 35052103)
44. Pearson AM, Young RB. Disease and disorders of muscle. Adv Food Nutr Res 1993;37:339-423.
45. Kieseier BC, Seifert T, Giovannoni G, Hartung HP. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurol 1999;53:20-25 (Pubitemid 29329643)
46. Roach DM, Fitridge RA, Laws PE, Millard SH, Varelias A, Cowled PA. Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg 2002;23:260-269 (Pubitemid 41079468)
47. Nosek TM, Brotto MA, Essig DA, Mestril R, Conover RC, Dillmann WH, Kolbeck RC. Functional properties of skeletal muscle from transgenic animals with upregulated heat shock protein 70. Physiol Genomics 2000; 4:25-33. (Pubitemid 33676677)
48. Takala TE, Virtanen P. Biochemical composition of muscle extracellular matrix: the effect of loading. Scand J Med Sci Sports 2000;10:321-325
49. Thompson LV. Skeletal muscle adaptations with age, inactivity, and therapeutic exercise. J Orthop Sports Phys Ther 2002;32:44-57.
50. Overall CM, Wrana JL, Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 1991;266:14064-14071 (Pubitemid 21907461)
51. Norenberg KM, Fitts RH. Contractile responses of the rat gastrocnemius and soleus muscles to isotonic resistance exercise. J Appl Physiol 2004;97:2322-2332
52. Arruda EM, Mundy K, Calve S, Baar K. Denervation does not change the ratio of collagen I and collagen III mRNA in the extracellular matrix of muscle. Am J Physiol Regul Integr Comp Physiol 2007;292:983-987 (Pubitemid 46207756)
53. Oishi Y, Taniguchi K, Matsumoto H, Ishihara A, Ohira Y, Roy R. Differential responses of HSPs to heat stress in slow and fast regions of rat gastrocnemius muscle. Muscle & Nerve 2003;28:587-594 (Pubitemid 37339913)
54. Pete D. Historical perspectives: plasticity of mammalian skeletal muscle. J Appl Physiol 2001;90:1119-1124